World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02923336
Date of registration: 02/10/2016
Prospective Registration: No
Primary sponsor: ALDO TORRE DELGADILLO
Public title: Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics
Scientific title: Evaluation of Gastrointestinal Transite in Cirrhotic Patient Pre and Post Treatment With Non Selective Betablockers (Propanolol)
Date of first enrolment: May 2015
Target sample size: 10
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02923336
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Mexico
Contacts
Name:     Jonathan Aguirre Valadez, MD
Address: 
Telephone: 55 27 55 80 49
Email: yanomani@hotmail.com
Affiliation: 
Name:     Aldo Torre Delgadillo
Address: 
Telephone:
Email: detoal@yahoo.mx
Affiliation: 
Name:     Aldo Torre Delgadillo
Address: 
Telephone:
Email:
Affiliation:  Instituto Nacional de Ciencias Medicas y NutriciĆ³n Salvador Zubiran
Key inclusion & exclusion criteria

Inclusion Criteria:

- Cirrhosis of any ethiology

- Child Pugh A, B, C without beta-blocker treatment previously (min. 1 month without
treatment)

- Patients with previous variceal bleeding (with liver cirrhosis) * Patients with
ascites or bacterial spontaneous peritonitis

Exclusion Criteria:

- Variceal disease without cirrhosis

- Cirrhotics patients that use antibiotics, prebiotics and probiotics during the study
period and one month previously

- Patients under immunosuppressor treatment

- Patients with portal thrombosis

- Patients with Sd. Budd-Chiari or cava/suprahepatic thrombosis

- Patients with active infection process



Age minimum: 18 Years
Age maximum: 65 Years
Gender: All
Health Condition(s) or Problem(s) studied
Liver Cirrhosis
Intervention(s)
Drug: non selective beta blocker
Primary Outcome(s)
Evaluatiuon of genes of tight junctions proteins before and after treatment with no selective betablocker [Time Frame: 4 weeks of maximum non betablocker dose]
Gastrointestinal transit time before and after treatment with no selective betablocker [Time Frame: 4 weeks of maximum non betablocker dose]
Secondary Outcome(s)
Secondary ID(s)
GAS-1068-13/15-1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history